Ttnp stock price to
WebInformation about Titan Pharmaceuticals Inc share price and performance, this page displays NASDAQ: TTNP stock exchange data. View historical data and performance … WebTTNP stock quote, chart and news. Get 's stock price today.
Ttnp stock price to
Did you know?
WebBased on 5 Wall Street analysts offering 12 month price targets for Aldeyra Therapeutics in the last 3 months. The average price target is $20.00 with a high forecast of $29.00 and a low forecast of $13.00. The average price target represents a 93.61% change from the last price of $10.33. Highest Price Target $29.00. Average Price Target $20.00. WebApr 14, 2024 · The stock has a 200-day moving average of $26.77 and traded as low as $25.50. Security Federal shares last traded at $25.50, with a volume of 107 shares changing hands. Security Federal Price Performance. The firm’s 50-day moving average price is $26.88 and its 200 day moving average price is $26.76.
WebTTNP Stock Summary. With a market capitalization of $10,928,025, TITAN PHARMACEUTICALS INC has a greater market value than only 4.59% of US stocks. With a … WebView Titan Pharmaceuticals, Inc TTNP investment & stock information. Get the latest Titan Pharmaceuticals, Inc TTNP detailed stock quotes, stock data, Real-Time ECN, charts, …
WebMar 20, 2024 · The current TTNP price target is $0.00. Learn why top analysts are making this price prediction for Titan Pharmaceuticals at MarketBeat. ... price targets are a mean … WebNov 20, 2024 · The gains in Titan Pharmaceuticals this morning seem to be the result of the fact that rumors are breaking surrounding the stock. According to the rumors, Pfizer Inc. (NYSE: PFE) will announce that it is buying TTNP. While there is a potential takeover, whoever is behind this rumor cut a big hole in their story right from the start.
WebMar 3, 2024 · Latest Titan Pharmaceuticals, Inc. Stock News. As of March 03, 2024, Titan Pharmaceuticals, Inc. had a $13.6 million market capitalization, putting it in the 13th percentile of companies in the Pharmaceuticals industry. Titan Pharmaceuticals, Inc. does not have a meaningful P/E due to negative earnings over the last 12 trailing months.
WebApr 13, 2024 · The stock was purchased at an average cost of $0.97 per share, with a total value of $36,375.00. Following the purchase, the chief executive officer now owns … cuffless tracheostomy careWebTitan Pharmaceuticals, Inc. Common Stock (TTNP) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. eastern district louisiana cmecfWebTTNP's dividend yield, history, payout ratio, proprietary DARS™ rating & much more! Dividend.com: The #1 Source For Dividend Investing. cuffless christmas stockingWebSupport: 888-992-3836 Home NewsWire Subscriptions ... cuffless visor beanieWebTitan Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. TTNP updated stock price target summary. cuffley activity centreWebJan 30, 2024 · TTNP stock forecast Our latest prediction for Titan Pharmaceuticals, Inc. (de)'s stock price was made on the Jan. 30, 2024 when the stock price was at 0.99$.. In … eastern district hs brooklyn nyWebNov 17, 2024 · Discover historical prices for TTNP stock on Yahoo Finance. View daily, weekly or monthly formats back to when Titan Pharmaceuticals, Inc. stock was issued. eastern district federal court st louis mo